A STUDY OF THE MECHANISM OF ESTROGEN AS AN ANTI-ATHEROSCLEROTIC - THE INHIBITORY EFFECT OF ESTROGEN ON A23187-INDUCED CONTRACTION OF THE AORTIC-WALL

被引:14
|
作者
KISHI, Y
NUMANO, F
机构
关键词
D O I
10.1016/0047-6374(82)90081-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:115 / 123
页数:9
相关论文
共 9 条
  • [1] Effect of estrogen on isoforms of nitric oxide synthase: Possible mechanism of anti-atherosclerotic effect of estrogen
    Hayashi, T
    Yamada, K
    Esaki, T
    Mutoh, E
    Iguchi, A
    GERONTOLOGY, 1997, 43 : 24 - 34
  • [2] Estrogen improves the eNOS dysfunction in hyperglycaemia-implication for anti-atherosclerotic effect of estrogen in diabetes
    Hayashi, T.
    Miyazaki-AKita, A.
    Iguchi, A.
    EUROPEAN HEART JOURNAL, 2005, 26 : 493 - 493
  • [3] TEMPORAL DIFFERENCES IN ANTI-ATHEROSCLEROTIC EFFECT OF ESTROGEN IN ALBINO-RATS
    MARTIN, DD
    HILBURN, F
    THIGPEN, A
    AMERICAN ZOOLOGIST, 1978, 18 (03): : 572 - 572
  • [4] 17β-estradiol improves the eNOS dysfunction in hyperglycemia:: implication for anti-atherosclerotic effect of estrogen
    Miyazaki, A
    Hayashi, T
    Matsui-Hirai, H
    Fukatsu, A
    Juliet, PAR
    Funami, J
    Iguchi, A
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2004, 11 (01): : 124 - 124
  • [5] STUDY ON ANTI-ATHEROSCLEROTIC EFFECT OF SUXIAO JIUXIN PILL AND ITS MECHANISM
    Guo, Qing-Xu
    Zhang, Jun
    Li, Yu-Qing
    Zhang, Gui-Fu
    AFRICAN JOURNAL OF TRADITIONAL COMPLEMENTARY AND ALTERNATIVE MEDICINES, 2014, 11 (01) : 97 - 102
  • [6] INHIBITORY EFFECT OF TNP-470, A NEW ANTI-ANGIOGENIC AGENT, ON THE ESTROGEN-INDUCED RAT PITUITARY-TUMORS
    TAKECHI, A
    UOZUMI, T
    KAWAMOTO, K
    ITO, A
    KURISU, K
    SUDO, K
    ANTICANCER RESEARCH, 1994, 14 (1A) : 157 - 162
  • [7] Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats
    Luo, SQ
    Stojanovic, M
    Labrie, C
    Labrie, F
    INTERNATIONAL JOURNAL OF CANCER, 1997, 73 (04) : 580 - 586
  • [8] Animal model for bevacizumab (anti-VEGF antibody) therapy for human endocrine tumors: Targeted inhibitory effect of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344
    Miyajima, K.
    Takekoshi, S.
    Miyakoshi, T.
    Ito, J.
    Kajiya, H.
    Egashira, N.
    Osamura, R. Y.
    MODERN PATHOLOGY, 2008, 21 : 108A - 108A
  • [9] Animal model for bevacizumab (Anti-VEGF antibody) therapy for human endocrine tumors: Targeted inhibitory effect of Anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in fischer 344 rats
    Miyajima, K.
    Takekoshi, S.
    Miyakoshi, T.
    Ito, J.
    Kajiya, H.
    Egashira, N.
    Osamura, R. Y.
    LABORATORY INVESTIGATION, 2008, 88 : 108A - 108A